Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
D000328:Adult; D001971:Bromocriptine / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects; D011388:Prolactin / Q000097:blood*
D004873:Ergolines; D001971:Bromocriptine; D007980:Levodopa; D011388:Prolactin; D008787:Metoclopramide